Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpresaria Group Regulatory News (EMR)

Share Price Information for Empresaria Group (EMR)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.00 (0.00%)
Bid:
21.00
Ask:
24.00
Spread: 3.00 (14.286%)
Market Cap: £11.04m
EMR Live PriceLast checked at - London Stock Exchange

Intraday Empresaria Group Share Chart

Trading Update

26 Oct 2021 07:00

RNS Number : 2008Q
Empresaria Group PLC
26 October 2021
 

26 October 2021

 

Empresaria Group plc

("Empresaria" or the "Group")

 

Trading update

 

Continued growth in profit forecast with Offshore Recruitment Services a key contributor

 

Empresaria, the global specialist staffing group, provides the market with an update on trading for the current financial year ending 31 December 2021.

 

Trading update

 

Following the progress made in the first half of 2021, we have seen increased momentum into the second half of the year as the Group continues to realise the benefits from operational initiatives and the improved economic environment. As a result, it is anticipated that the Group's full year net fee income will be in the range of £57m to £59m and adjusted profit before tax is expected to be in the range of £7.4m to £7.9m (9% to 16% above market consensus).

 

Our Offshore Recruitment Services sector continues to go from strength to strength and delivered a record increase in billable headcount in September. This sector remains core to our future plans through both its external and internal delivery.

 

Our Professional sector has performed better than expected in the third quarter with a strong recovery in our UK hospitality operations and solid performances in Asia despite the very significant levels of local lockdowns. However, the challenges in the aviation industry continue and this is expected to impact us until the sector recovers.

 

Our Healthcare sector has had a very strong 2021. While we were anticipating a significant slowdown in the vaccination programmes in our Healthcare sector in the second half of the year, the autumn COVID-19 booster vaccinations in the US have led to additional demand. This will likely last through to early 2022 after which we expect reduced demand from the vaccination programme.

 

Chief Executive Officer, Rhona Driggs, commented:

 

"I am pleased we are able to deliver this positive news on our trading. Demand continues to be strong across the staffing industry and we are seeing this reflected in most of our businesses. With skills shortages at a 15-year high, candidate attraction and engagement remain a key priority as we close out the year. We are continuing to invest in the future of the business, including the recent appointment of regional leaders who will be instrumental in helping us deliver on our growth strategies. I am pleased to see the positive momentum within the business, and I am confident that we can take advantage of the continued economic recovery to deliver long-term growth."

 

- Ends -

 

Enquiries:

Empresaria Group plcRhona Driggs, Chief Executive OfficerTim Anderson, Chief Financial Officer

via Alma PR

Singer Capital Markets (Nominated Adviser and Broker)Shaun Dobson / James Moat

020 7496 3000

Alma PR (Financial PR)Sam Modlin

David Ison

Hilary Buchanan

020 3405 0205empresaria@almapr.com

 

Notes for editors:

§ Empresaria Group plc is a global specialist staffing group offering temporary and contract recruitment, permanent recruitment and offshore recruitment services across 6 sectors: Professional; IT; Healthcare; Property, Construction and Engineering; Commercial and Offshore Recruitment Services.

 

§ Empresaria operates from locations across the world including the 4 largest staffing markets of the US, Japan, UK and Germany along with a strong presence elsewhere in Asia Pacific and Latin America.

 

§ Empresaria is listed on AIM under ticker EMR. For more information visit empresaria.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKELFLFBLZFBB
Date   Source Headline
12th May 20217:00 amRNSTransaction in Own Shares
11th May 20217:00 amRNSTransaction in Own Shares
6th May 20217:00 amRNSSenior Leadership Appointments
4th May 20217:00 amRNSTransaction in Own Shares
29th Apr 20217:00 amRNSTransaction in Own Shares
28th Apr 20217:00 amRNSTransaction in Own Shares
23rd Apr 20217:00 amRNSTransaction in Own Shares
13th Apr 20217:00 amRNSAnnual Report and Accounts and Notice of AGM
12th Apr 202112:28 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSTransaction in Own Shares
26th Mar 20212:54 pmRNSDirector/PDMR Shareholding
19th Mar 20217:00 amRNSTransaction in Own Shares
18th Mar 20217:00 amRNSFinal Results
2nd Mar 20217:00 amRNSInvestor Meet Company Presentation
22nd Feb 20212:19 pmRNSHolding(s) in Company
28th Jan 20217:00 amRNSTrading Update and Notice of Results
22nd Dec 20201:18 pmRNSTransaction in Own Shares & Total Voting Rights
18th Dec 20209:41 amRNSTransaction in Own Shares
2nd Dec 20207:55 amRNSTransaction in Own Shares
2nd Dec 20207:00 amRNSTrading Update
12th Nov 20207:00 amRNSTransaction in Own Shares
5th Nov 20207:00 amRNSTransaction in Own Shares
29th Oct 20201:38 pmRNSHolding(s) in Company
7th Oct 202010:02 amRNSTransaction in Own Shares
6th Oct 20207:00 amRNSTransaction in Own Shares
25th Sep 20202:56 pmRNSTransaction in Own Shares
22nd Sep 20207:00 amRNSTransaction in Own Shares
9th Sep 20205:39 pmRNSTransaction in Own Shares
8th Sep 20203:15 pmRNSDirector / PDMR Shareholding
18th Aug 20207:00 amRNSTransaction in Own Shares
12th Aug 20207:00 amRNSInterim Results
10th Aug 20207:00 amRNSInvestor Meet Company presentation
31st Jul 20207:00 amRNSRevision: Trading Update and Notice of Results
22nd Jul 20207:00 amRNSTrading Update and Notice of Results
1st Jul 20203:36 pmRNSTransaction in Own Shares
30th Jun 202012:40 pmRNSTransaction in Own Shares
25th Jun 20208:54 amRNSTransaction in Own Shares
17th Jun 20205:18 pmRNSShare Buyback Programme
27th May 20201:04 pmRNSDirector/PDMR Shareholding
26th May 20201:23 pmRNSResult of AGM
26th May 20207:00 amRNSTrading update, acq. of non-controlling interest
8th Apr 20207:00 amRNSTrading and COVID-19 Update and Notice of AGM
30th Mar 20204:32 pmRNSAwards pursuant to the Company's LTIP
20th Mar 202012:08 pmRNSDirector/PDMR Shareholding
18th Mar 20201:10 pmRNSDirector Dealing
18th Mar 20207:00 amRNSFinal Results
6th Mar 20207:00 amRNSChange of Nominated Adviser and Broker
5th Feb 20202:53 pmRNSHolding(s) in Company
29th Jan 20207:00 amRNSTrading Update and Notice of Results
3rd Dec 201910:36 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.